Sutro Biopharma Inc (NASDAQ: STRO) on Friday, plunged -13.36% from the previous trading day, before settling in for the closing price of $0.94. Within the past 52 weeks, STRO’s price has moved between $0.52 and $4.60.
Healthcare Sector giant saw their annual sales slid by -4.05% over the last five years. The company achieved an average annual earnings per share of 37.53%. With a float of $78.55 million, this company’s outstanding shares have now reached $85.10 million.
Sutro Biopharma Inc (STRO) Insider Activity
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Sutro Biopharma Inc is 7.73%, while institutional ownership is 65.80%. The most recent insider transaction that took place on Oct 15 ’25, was worth 13,607. In this transaction CHIEF SCIENTIFIC OFFICER of this company bought 17,000 shares at a rate of $0.80, taking the stock ownership to the 71,832 shares. Before that another transaction happened on Oct 15 ’25, when Company’s CFO bought 19,750 for $0.81, making the entire transaction worth $15,998. This insider now owns 19,750 shares in total.
Sutro Biopharma Inc (STRO) Earnings and Forecasts
As on 12/31/2024, Multinational firm has announced its last quarter scores, in which it reported -0.63 earnings per share (EPS) for the period topping the consensus outlook (set at -0.95) by 0.32. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.42 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 37.53% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 31.82% during the next five years compared to -4.05% drop over the previous five years of trading.
Sutro Biopharma Inc (NASDAQ: STRO) Trading Performance Indicators
Sutro Biopharma Inc (STRO) is currently performing well based on its current performance indicators. A quick ratio of 2.53 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.66.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.60, a number that is poised to hit -0.40 in the next quarter and is forecasted to reach -1.13 in one year’s time.
Technical Analysis of Sutro Biopharma Inc (STRO)
Analysing the last 5-days average volume posted by the [Sutro Biopharma Inc, STRO], we can find that recorded value of 0.76 million was lower than the volume posted last year of 1.18 million. As of the previous 9 days, the stock’s Stochastic %D was 10.32%.
During the past 100 days, Sutro Biopharma Inc’s (STRO) raw stochastic average was set at 22.42%, which indicates a significant increase from 6.83% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1190 in the past 14 days, which was higher than the 0.0795 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.9485, while its 200-day Moving Average is $1.0000. Now, the first resistance to watch is $0.8892. This is followed by the second major resistance level at $0.9622. The third major resistance level sits at $1.0167. If the price goes on to break the first support level at $0.7617, it is likely to go to the next support level at $0.7072. Should the price break the second support level, the third support level stands at $0.6342.
Sutro Biopharma Inc (NASDAQ: STRO) Key Stats
Market capitalization of the company is 69.50 million based on 84,774K outstanding shares. Right now, sales total 62,040 K and income totals -227,460 K. The company made 63,750 K in profit during its latest quarter, and -11,500 K in sales during its previous quarter.
